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Erratum
The following is the correct afﬁliation information for the article, “Economic Evaluation Of Voriconazole versus Con-
ventional Amphotericin B in the Treatment of Invasive Aspergillosis in Germany,” which appeared in Value in Health,
Volume 9, Issue 1 (January/February 2006):
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